Pfizer Inc

Healthcare · Drug Manufacturers - General

27.70$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Pfizer Inc (PFE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 62,579 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PFE
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	11,306	12,504	13,544	16,204	29,574	32,259	32,373	45,188	52,516	47,405	48,371	48,428	48,296	50,009	67,057	61,035	54,657	51,584	49,605	48,851	52,824	52,546	53,647	41,172	41,651	81,288	100,330	59,553	63,627	62,579
Cost of Revenue	1,746	1,772	1,605	1,986	4,059	5,034	4,045	9,832	10,905	10,507	10,509	11,725	10,035	11,590	20,714	17,165	14,642	13,954	13,310	13,157	15,954	15,777	16,008	12,623	11,771	34,413	38,240	29,213	21,781	18,565
Gross Profit	9,560	10,732	11,939	14,218	25,515	27,225	28,328	35,356	41,611	36,898	37,862	36,703	38,261	38,419	46,343	43,870	40,015	37,630	36,295	35,694	36,870	36,769	37,639	28,549	29,880	46,875	62,090	30,340	41,846	44,014
Research & Development	–	1,928	2,279	2,776	4,435	4,847	5,176	7,131	7,620	7,206	7,423	7,573	7,512	7,754	9,358	8,004	6,955	6,551	8,310	7,671	7,840	7,645	7,967	8,364	9,395	13,828	11,426	10,578	10,738	11,976
Selling, General & Administrative	6,050	4,956	5,568	6,351	11,442	11,299	10,846	15,242	16,903	16,997	15,589	15,626	14,537	14,875	19,614	19,468	13,816	11,355	10,997	11,709	11,637	11,684	11,755	12,050	9,815	10,703	10,877	11,071	11,430	13,642
Total Operating Expenses	6,480	7,386	8,336	9,669	16,845	16,249	16,050	24,556	24,523	22,368	22,769	22,780	21,636	22,410	28,611	25,488	21,976	20,742	22,266	22,398	22,596	22,378	22,350	21,038	20,795	26,082	24,541	25,048	25,363	28,577
Operating Income	3,080	3,346	3,603	4,549	8,670	10,976	12,278	10,800	17,088	14,530	15,093	13,923	16,625	16,009	17,732	18,382	18,039	16,888	14,029	13,296	14,274	14,391	15,289	7,511	9,085	20,793	37,549	5,292	16,483	15,437
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	347	471	488	397	516	1,233	1,797	1,681	1,522	1,414	1,360	1,199	1,186	1,270	1,316	1,573	1,449	1,291	1,238	2,209	3,091	2,671
Pre-Tax Income	2,798	3,078	2,592	4,443	5,767	10,329	11,796	3,263	14,007	10,800	13,028	9,278	9,694	10,827	9,282	11,481	11,242	15,716	12,240	8,965	8,351	12,305	11,885	11,485	7,036	24,311	34,729	1,058	8,023	7,520
Income Tax Expense	869	865	-642	1,244	2,049	2,561	2,609	1,621	2,665	3,178	1,992	1,023	1,645	2,197	1,071	3,621	2,221	4,306	3,121	1,990	1,122	-9,048	706	618	370	1,852	3,328	-1,114	-28	-266
Net Income	1,929	2,213	3,351	3,179	3,726	7,788	9,126	3,910	11,332	7,610	11,024	8,210	8,024	8,635	8,268	8,705	9,787	11,649	9,080	6,966	7,215	21,305	11,153	16,273	9,159	22,147	31,365	2,133	8,020	7,770
EBITDA	3,102	3,501	6,148	7,867	9,538	11,586	13,257	14,390	19,447	16,847	18,809	14,875	15,300	16,817	19,566	22,188	20,419	23,540	19,137	15,321	15,294	19,844	19,585	18,853	13,168	30,793	41,031	9,557	18,127	15,096

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings